Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

Share Price is delayed by 15 minutes
Get Live Data
125.50    0.00 (0.00%)
Bid:
123.00
Ask:
128.00
Spread: 5.00 (4.065%)
Market Cap: £214.10m
NET Live PriceLast checked at - London Stock Exchange

Intraday Netcall Share Chart

AGM Statement

17 Dec 2020 07:00

RNS Number : 9147I
Netcall PLC
17 December 2020
 

17 December 2020

 

NETCALL PLC

 

("Netcall", the "Company" or the "Group")

 

AGM Statement

 

Netcall plc (AIM: NET), a leading provider of intelligent automation and customer engagement software, is pleased to provide the following update ahead of the Company's Annual General Meeting to be held at 10:30am today.

 

Netcall's strong momentum has continued in the first half of FY21 with trading in line with management expectations. Order levels to date are significantly higher than the same period last year, driven by demand for low code and customer engagement solutions across key market segments of healthcare, government and financial services. Cloud annual contract value (ACV) continues to grow and is approximately 30% higher than the same period last year. The Group has a healthy pipeline of opportunities, supported by an acceleration of organisations' digital transformation initiatives.

 

Recent customer successes include Tesco Underwriting, who developed a claims handling process using Netcall's low code platform, which delivered a 57% increase in the number of claims processed per hour. Additionally, the Group supported Cardiff City Council to help streamline the surge in COVID-related calls they are receiving in relation to the Test, Trace and Protect initiative.

 

Netcall continues to innovate across its software platform, launching a number of COVID-19 related solutions to support the Group's healthcare customers. These include a Waiting List Management App to assist hospitals find a rapid solution for the increase in patient waiting lists, and a Vaccinations App to help the NHS plan and manage the roll-out of COVID-19 vaccines for staff.

 

The initial customer response to the increased breadth of the Liberty platform, through the acquisition of RPA vendor, Automagica, has been very positive, and Netcall continues with the integration of Automagica's RPA solution onto the Liberty platform launching in January 2021.

 

Looking ahead, whilst the Board remains mindful of the current economic disruptions on our customers, it is confident that the strength of the Group's product offering combined with its strong balance sheet and high levels of recurring revenue have positioned Netcall well for continued success.

 

 

 

For further enquiries, please contact:

Netcall plc

Tel. +44 (0) 330 333 6100

Henrik Bang, CEO

Michael Jackson, Chairman

James Ormondroyd, Group Finance Director

Canaccord Genuity Limited (Nominated Adviser and Broker) 

Tel. +44 (0) 20 7523 8000

Simon Bridges / Andrew Potts

Alma PR

Tel. +44 (0) 20 3405 0205

Caroline Forde / Josh Royston / Helena Bogle / Robyn Fisher

About Netcall

Netcall's Liberty software platform with Intelligent Automation and Customer Engagement solutions helps organisations transform their businesses faster and more efficiently, empowering them to create a leaner, more customer-centric organisation.

 

Netcall's customers span enterprise, healthcare and government sectors. These include two-thirds of the NHS Acute Health Trusts and leading corporates such as Legal and General, Lloyds Banking Group, ITV and Nationwide Building Society.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLDFDLRLII
Date   Source Headline
27th May 20268:03 amRNSHolding(s) in Company
14th May 20263:07 pmRNSDirector/PDMR Shareholding
11th May 20263:10 pmRNSNotification of major holdings
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSIssue of Contingent Consideration Shares & TVR
17th Mar 20265:40 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSHalf-year Report
22nd Jan 20267:00 amRNSTrading Update and Notice of Results
7th Jan 20267:00 amRNS-R£3.0m Liberty Cloud Contract Win
17th Dec 20251:24 pmRNSResult of AGM
17th Dec 20257:00 amRNSAGM Statement
10th Dec 20257:00 amRNSAcquisition of Jadu Holdings Limited
20th Nov 20257:00 amRNSNotice of AGM and Posting of Annual Report
19th Nov 20257:00 amRNSIssue of Contingent Consideration Shares & TVR
29th Oct 20252:26 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
25th Sep 20252:49 pmRNSNotice of Results
22nd Aug 202511:48 amRNSHolding(s) in Company
4th Aug 20258:53 amRNSHolding(s) in Company
29th Jul 202512:41 pmRNSDirector/PDMR Shareholding
24th Jul 20253:34 pmRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSFY25 Trading Update
15th May 20257:00 amRNSExercise of Options and Total Voting Rights
15th Apr 20258:10 amRNSHolding(s) in Company
9th Apr 20253:52 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAIM Rule 17 – Notification of shareholding
19th Mar 202511:12 amRNSHolding(s) in Company
19th Mar 202510:04 amRNSDirector/PDMR Shareholding
13th Mar 20254:44 pmRNSExercise of Options and Total Voting Rights
10th Mar 20253:56 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSHalf-year Report
29th Jan 20255:51 pmRNSExercise of Options and Total Voting Rights
28th Jan 20255:41 pmRNSHolding(s) in Company
24th Jan 202511:58 amRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
9th Jan 20257:00 amRNSDirector/PDMR Shareholding
6th Jan 20253:27 pmRNSDirector/PDMR Shareholding
31st Dec 20247:00 amRNSEstablishment of New Long-Term Incentive Plan
18th Dec 20242:05 pmRNSHolding(s) in Company
18th Dec 202410:09 amRNSHolding(s) in Company
17th Dec 202411:44 amRNSResult of AGM
17th Dec 20247:00 amRNSAGM Statement
5th Dec 20243:54 pmRNSHolding(s) in Company
4th Dec 20244:04 pmRNSHolding(s) in Company
29th Nov 20245:21 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSNotice of AGM and Posting of Annual Report
15th Nov 202412:15 pmRNSHolding(s) in Company
7th Nov 20243:39 pmRNSExercise of Options and Total Voting Rights
25th Oct 20247:00 amRNSExercise of Options, Director/PDMR Dealing and TVR
14th Oct 20242:03 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.